ad-35
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 12, 2018 (NCT03625401)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03790982 | Phase 2 | Dec 1, 2018 | Capital Medical University, Zhejiang Hisun Pharmaceutical Co. Ltd. |
| NCT03625401 | Phase 2 | Aug 12, 2018 | Medpace, Inc., Zhejiang Hisun Pharmaceutical Co. Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang Hisun Pharmaceutical Co. Ltd. | For profit | 2 | 2 | 1 | 2018 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Medpace, Inc. | For profit | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1